245 related articles for article (PubMed ID: 30300141)
61. Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells.
Friedman KM; Garrett TE; Evans JW; Horton HM; Latimer HJ; Seidel SL; Horvath CJ; Morgan RA
Hum Gene Ther; 2018 May; 29(5):585-601. PubMed ID: 29641319
[TBL] [Abstract][Full Text] [Related]
62. Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor-Alpha Production in Mice after Bone Marrow Transplantation.
Liu J; Guo YM; Onai N; Ohyagi H; Hirokawa M; Takahashi N; Tagawa H; Ubukawa K; Kobayashi I; Tezuka H; Minamiya Y; Ohteki T; Sawada K
Biol Blood Marrow Transplant; 2016 Apr; 22(4):627-636. PubMed ID: 26740374
[TBL] [Abstract][Full Text] [Related]
63. Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma.
Herth I; Witzens-Harig M; Beckhove P; Hose D; Meissner T; Neuber B; Engelhardt M; Haas J; Neben K; Ho AD; Klein B; Goldschmidt H; Hundemer M
Exp Hematol; 2013 Mar; 41(3):231-40. PubMed ID: 23142220
[TBL] [Abstract][Full Text] [Related]
64. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
[TBL] [Abstract][Full Text] [Related]
65. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
66. Adoptive cell therapy using PD-1
Jing W; Gershan JA; Blitzer GC; Palen K; Weber J; McOlash L; Riese M; Johnson BD
J Immunother Cancer; 2017; 5():51. PubMed ID: 28642819
[TBL] [Abstract][Full Text] [Related]
67. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.
Bi E; Li R; Bover LC; Li H; Su P; Ma X; Huang C; Wang Q; Liu L; Yang M; Lin Z; Qian J; Fu W; Liu YJ; Yi Q
J Clin Invest; 2018 Nov; 128(11):4821-4831. PubMed ID: 30277474
[TBL] [Abstract][Full Text] [Related]
68. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
[TBL] [Abstract][Full Text] [Related]
69. Interleukin-27 signaling promotes immunity against endogenously arising murine tumors.
Natividad KD; Junankar SR; Mohd Redzwan N; Nair R; Wirasinha RC; King C; Brink R; Swarbrick A; Batten M
PLoS One; 2013; 8(3):e57469. PubMed ID: 23554861
[TBL] [Abstract][Full Text] [Related]
70. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
Huang H; Li F; Gordon JR; Xiang J
Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
[TBL] [Abstract][Full Text] [Related]
71. Antitumor vaccination with gene-transduced tumor cells expressing a fusion protein RM4/IFN-tau.
Xiang J
Cancer Biother Radiopharm; 1997 Apr; 12(2):123-30. PubMed ID: 10851456
[TBL] [Abstract][Full Text] [Related]
72. Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection.
Gowdy KM; Martinu T; Nugent JL; Manzo ND; Zhang HL; Kelly FL; Holtzman MJ; Palmer SM
Transpl Immunol; 2015 Jan; 32(1):51-60. PubMed ID: 25446809
[TBL] [Abstract][Full Text] [Related]
73. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
74. Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment.
Nakamura K; Kassem S; Cleynen A; Chrétien ML; Guillerey C; Putz EM; Bald T; Förster I; Vuckovic S; Hill GR; Masters SL; Chesi M; Bergsagel PL; Avet-Loiseau H; Martinet L; Smyth MJ
Cancer Cell; 2018 Apr; 33(4):634-648.e5. PubMed ID: 29551594
[TBL] [Abstract][Full Text] [Related]
75. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumour-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma.
Chiriva-Internati M; Wang Z; Salati E; Wroblewski D; Lim SH
Scand J Immunol; 2002 Oct; 56(4):429-33. PubMed ID: 12234264
[TBL] [Abstract][Full Text] [Related]
76. OX40 and Bcl-xL promote the persistence of CD8 T cells to recall tumor-associated antigen.
Song A; Tang X; Harms KM; Croft M
J Immunol; 2005 Sep; 175(6):3534-41. PubMed ID: 16148096
[TBL] [Abstract][Full Text] [Related]
77. Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect.
Bertz H; Burger JA; Kunzmann R; Mertelsmann R; Finke J
Leukemia; 1997 Feb; 11(2):281-3. PubMed ID: 9009093
[TBL] [Abstract][Full Text] [Related]
78. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
[TBL] [Abstract][Full Text] [Related]
79. Immunotherapy of multiple myeloma.
Minnie SA; Hill GR
J Clin Invest; 2020 Apr; 130(4):1565-1575. PubMed ID: 32149732
[TBL] [Abstract][Full Text] [Related]
80. Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells.
Barber A; Meehan KR; Sentman CL
Gene Ther; 2011 May; 18(5):509-16. PubMed ID: 21209626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
